No Data
No Data
Cytek Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems
Today Cytek Biosciences, Inc. (NASDAQ:CTKB), a leading cell analysis solutions company, officially announced its Enhanced Small Particle (ESP™) Detection Option for its flagship Cytek Aurora™ and Cytek Northern Lights™ cell analysis systems.
Analysts Have Conflicting Sentiments on These Healthcare Companies: Cytek Biosciences (CTKB), Elanco Animal Health (ELAN) and Atara Biotherapeutics (ATRA)
Cytek Biosciences Is Maintained at Overweight by Piper Sandler
Cytek Biosciences Is Maintained at Overweight by Piper Sandler
Cytek Biosciences Price Target Cut to $8.50/Share From $10.00 by Piper Sandler
Cytek Biosciences Price Target Cut to $8.50/Share From $10.00 by Piper Sandler
Express News | Piper Sandler Maintains Overweight on Cytek Biosciences, Lowers Price Target to $8.5
Cytek Biosciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/13/2024 34.92% Piper Sandler $10 → $8.5 Maintains Overweight 03/06/2024 58.73% Piper Sandler $11 → $10
No Data